Skip to content
easybpt
Browse topics

Pharmacology

Safe opioid prescribing and opioid stewardship

The pharmacology behind opioid harm, oral morphine equivalent daily dose and the risk thresholds, the evidence on opioids in chronic non-cancer pain, Australian regulation (TGA 2020 changes, codeine rescheduling, take-home naloxone, real-time monitoring) and the ACSQHC acute pain stewardship standard.

Tier 1Medical sciences concept

Written with AI assistance and fact-checked against the sources below. For exam study, not clinical decisions. How notes are made

3 questions8 flashcards

At a glance

  • Opioid harm follows from pharmacology: dose-related respiratory depression, potentiation by other CNS depressants, tolerance, dependence and hyperalgesia.
  • Express total exposure as oMEDD using the ANZCA Faculty of Pain Medicine factors (October 2025 update).
  • ANZCA's Appendix 2 states that oMEDD above 40 mg carries about a four-fold, and above 100 mg about an eleven-fold, increase in cardiorespiratory events. The underlying cohort studies band dose differently: compared with 1 to 20 mg/day, overdose risk is about 4-fold at 50 to 99 mg and about 9-fold at 100 mg or more (Dunn 2010), with Bohnert 2011 giving 5- to 12-fold at 100 mg or more depending on indication.

Loading the rest of the note…

Finished reading?

Test yourself on it:3 questions8 flashcards

Sources

Last updated
14 November 2026
What changed
  • 14 November 2026 Turnstile bot check on sign-in and signed-out feedback

Send feedback

Type of feedback

The page you're on and your device type are attached automatically.